Menu Search
Equities

Burcon NutraScience Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BRCNF:QBB

Burcon NutraScience Corp

Actions
  • Price (USD)1.36
  • Today's Change-0.039 / -2.80%
  • Shares traded475.00
  • 1 Year change-1.45%
  • Beta2.8913
Data delayed at least 15 minutes, as of Feb 17 2026 17:48 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Burcon NutraScience Corporation is a Canada-based global technology company focused on the development of plant-based proteins for foods and beverages. The Company has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. It is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. It extracts and purifies a canola protein isolate from canola meal. It has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. It also operates a protein production facility located in Galesburg, Illinois.

  • Revenue in CAD (TTM)803.70k
  • Net income in CAD-11.11m
  • Incorporated1998
  • Employees15.00
  • Location
    Burcon NutraScience Corp490-999 West BroadwayVANCOUVER V5Z 1K5CanadaCAN
  • Phone+1 (604) 733-0896
  • Fax+1 (604) 733-0896
  • Websitehttps://www.burcon.ca/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.